Ruthless Spine Announces Intellectual Property News and 510(k) Clearance on Revolutionary Spinal Instrument
Ruthless Spine today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the NavJam™ Jamshidi device, and as of today, U.S. Patent Office records indicate that the status of the NavJam™ Jamshidi patent application is allowed. The NavJam™ Jamshidi device is also covered by an issued Taiwan patent and is designed to work in tandem with Ruthless Spine’s De Novo cleared RJB™ intraoperative angle measurement instrument.
